Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 3:01 AM ET

Healthcare Equipment and Supplies

Company Overview of Tenaxis Medical, Inc.

Company Overview

Tenaxis Medical, Inc. develops and markets sealants and anti-adhesion agents for vascular and general surgical markets. The company’s products include ArterX vascular sealant, a prophylactic agent that seals anastomotic suture lines; and ArterX self-mixing syringe, which is used to mix and apply the sealant's components, as well as in the precise placement of the sealant. It also focuses on developing a sealant for use in the gastrointestinal tract; and an anti-adhesion agent that can be delivered laparoscopically to prevent pelvic and abdominal adhesions. The company offers its products through distributors in Denmark, Germany, Greece, Ireland, Italy, the Netherlands, South Africa, Spain, S...

835 Maude Avenue

Mountain View, CA 94043

United States

Founded in 2004





Key Executives for Tenaxis Medical, Inc.

Founder, Executive Chairman and Chief Executive Officer
Chief Financial Officer
Compensation as of Fiscal Year 2015.

Tenaxis Medical, Inc. Key Developments

Tenaxis Medical, Inc. Receives CE Mark Approval to Expand Indications for its Arterx(R) Surgical Sealant

Tenaxis Medical, Inc. has received approval from its EU Notified Body, BSI, to expand its CE Mark indications for ArterX Surgical Sealant. ArterX Surgical Sealant is designed to be applied directly over suture or staple line to achieve hemostasis during surgery to seal the area to stop and prevent leaks. The intended use for the product has now been expanded for use in cardiac, vascular and soft tissue reconstructions. This includes a wide variety of surgical procedures including the vasculature and major organs that involve bleeding or leakage. Approved CE Mark indications and usage specified in the new product labeling include: Cardiac Reconstructions: Aortic root replacement, aortoplasty, aortic valve procedures, valve procedures, Bentall procedure, composite valve conduit procedure, mitral valve replacement, Ross procedure, proximal coronary anastomoses, aortic aneurysm repairs, aortic wall replacement, ascending aorta repair. Peripheral Vascular Reconstructions: Aorto-femoral bypass, aorto-iliac bypass, aortic bypass, aorto-innominate bypass, carotid bypass, carotid endarterectomy, femoral-distal bypass, femoral-femoral bypass, femoral-popliteal bypass, hepatic-renal bypass, popliteal-dorsalis pedis bypass, profunda endarterectomy, renal bypass, extremity bypass, renal endarterectomy, hemodialysis access, arteriovenous graft. Soft Tissue Repair Involving Sutures and Staples: Cardiac wound repair, pancreatic anastomotic leak, hepatic resection, splenic bleeding, biliary leaks, esophageal repair, colorectal repair, stapled gastrojejunostomy and lymphatic leaks.

Similar Private Companies By Industry

Company Name Region
Leto Solutions, Inc. United States
Reliant Healthcare Solutions, Inc. United States
Common Sensing Inc. United States
Anatomic Concepts, Inc. United States
Valley Orthopedic Incorporated United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tenaxis Medical, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at